Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

102 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Effect of Fractional Carbon Dioxide vs Sham Laser on Sexual Function in Survivors of Breast Cancer Receiving Aromatase Inhibitors for Genitourinary Syndrome of Menopause: The LIGHT Randomized Clinical Trial.
Mension E, Alonso I, Anglès-Acedo S, Ros C, Otero J, Villarino Á, Farré R, Saco A, Vega N, Castrejón N, Ordi J, Rakislova N, Tortajada M, Matas I, Gómez S, Ribera L, Castelo-Branco C. Mension E, et al. Among authors: tortajada m. JAMA Netw Open. 2023 Feb 1;6(2):e2255697. doi: 10.1001/jamanetworkopen.2022.55697. JAMA Netw Open. 2023. PMID: 36763359 Free PMC article. Clinical Trial.
Tolerability and Reactogenicity Profile of mRNA SARS-Cov-2 Vaccines from a Mass Vaccination Campaign in a Tertiary Hospital: Between-Vaccine and Between-Population Prospective Observational Study (VigilVacCOVID Study).
Sáez-Peñataro J, Torres F, Bartra J, Bascuas J, Vilella A, Tortajada M, Quesada S, González E, López-Suñé E, Castells A, Serrano S, Camacho C, Trilla A, Calvo G; VigilVacCOVID Group. Sáez-Peñataro J, et al. Among authors: tortajada m. BioDrugs. 2022 Jul;36(4):509-520. doi: 10.1007/s40259-022-00543-9. Epub 2022 Jun 28. BioDrugs. 2022. PMID: 35764768 Free PMC article.
A Prospective Cohort of SARS-CoV-2-Infected Health Care Workers: Clinical Characteristics, Outcomes, and Follow-up Strategy.
Nicolás D, Camós-Carreras A, Spencer F, Arenas A, Butori E, Maymó P, Anmella G, Torrallardona-Murphy O, Alves E, García L, Pereta I, Castells E, Seijas N, Ibáñez B, Grané C, Bodro M, Cardozo C, Barroso S, Olive V, Tortajada M, Hernández C, Cucchiari D, Coloma E, Pericàs JM; Hospital Clinic Hospital at Home Team. Nicolás D, et al. Among authors: tortajada m. Open Forum Infect Dis. 2020 Dec 8;8(1):ofaa592. doi: 10.1093/ofid/ofaa592. eCollection 2021 Jan. Open Forum Infect Dis. 2020. PMID: 33537362 Free PMC article.
RBD-Based ELISA and Luminex Predict Anti-SARS-CoV-2 Surrogate-Neutralizing Activity in Two Longitudinal Cohorts of German and Spanish Health Care Workers.
Aguilar R, Li X, Crowell CS, Burrell T, Vidal M, Rubio R, Jiménez A, Hernández-Luis P, Hofmann D, Mijočević H, Jeske S, Christa C, D'Ippolito E, Lingor P, Knolle PA, Roggendorf H, Priller A, Yazici S, Carolis C, Mayor A, Schreiner P, Poppert H, Beyer H, Schambeck SE, Izquierdo L, Tortajada M, Angulo A, Soutschek E, Engel P, Garcia-Basteiro A, Busch DH, Moncunill G, Protzer U, Dobaño C, Gerhard M. Aguilar R, et al. Among authors: tortajada m. Microbiol Spectr. 2023 Feb 14;11(1):e0316522. doi: 10.1128/spectrum.03165-22. Epub 2023 Jan 9. Microbiol Spectr. 2023. PMID: 36622140 Free PMC article.
Circulating extracellular vesicles and neutrophil extracellular traps contribute to endothelial dysfunction in preeclampsia.
Ramos A, Youssef L, Molina P, Torramadé-Moix S, Martinez-Sanchez J, Moreno-Castaño AB, Blasco M, Guillén-Olmos E, De Moner B, Pino M, Tortajada M, Camacho M, Borrell M, Crovetto F, Ramirez-Bajo MJ, Ventura-Aguiar P, Banon-Maneus E, Rovira J, Escolar G, Carreras E, Gratacos E, Diaz-Ricart M, Crispi F, Palomo M. Ramos A, et al. Among authors: tortajada m. Front Immunol. 2024 Dec 13;15:1488127. doi: 10.3389/fimmu.2024.1488127. eCollection 2024. Front Immunol. 2024. PMID: 39735539 Free PMC article.
[No title available]
[No authors listed] [No authors listed] PMID: 39249373
Correlates of protection and determinants of SARS-CoV-2 breakthrough infections 1 year after third dose vaccination.
Martín Pérez C, Aguilar R, Jiménez A, Salmerón G, Canyelles M, Rubio R, Vidal M, Cuamba I, Barrios D, Díaz N, Santano R, Serra P, Santamaria P, Izquierdo L, Trilla A, Vilella A, Barroso S, Tortajada M, García-Basteiro AL, Moncunill G, Dobaño C. Martín Pérez C, et al. Among authors: tortajada m. BMC Med. 2024 Mar 8;22(1):103. doi: 10.1186/s12916-024-03304-3. BMC Med. 2024. PMID: 38454385 Free PMC article.
[No title available]
[No authors listed] [No authors listed] PMID: 39249719
Immunogenicity of a third dose with mRNA-vaccines in the ChAdOx1-S/BNT162b2 vaccination regimen against SARS-CoV-2 variants.
García-Pérez J, Borobia AM, Pérez-Olmeda M, Portolés A, Castaño L, Campins-Artí M, Bertrán MJ, Bermejo M, Arribas JR, López A, Ascaso-Del-Rio A, Arana-Arri E, Fuentes Camps I, Vilella A, Cascajero A, García-Morales MT, Castillo de la Osa M, Pérez Ingidua C, Lora D, Jiménez-Santana P, Pino-Rosa S, Gómez de la Cámara A, De La Torre-Tarazona E, Calonge E, Cruces R, Belda-Iniesta C, Alcamí J, Frías J, Carcas AJ, Díez-Fuertes F; CombiVacS Study Group. García-Pérez J, et al. iScience. 2024 Aug 14;27(9):110728. doi: 10.1016/j.isci.2024.110728. eCollection 2024 Sep 20. iScience. 2024. PMID: 39286494 Free PMC article.
102 results